Literature DB >> 19171400

The paradox of high apolipoprotein A-I levels independently predicting incident type-2 diabetes among Turks.

A Onat1, G Hergenç, S Bulur, M Uğur, Z Küçükdurmaz, G Can.   

Abstract

BACKGROUND: Predictive value of apolipoprotein (apo) A-I for incident hypertension, metabolic syndrome (MetS), type 2 diabetes (DM) and coronary heart disease (CHD) needs further exploration.
METHODS: A representative sample of Turkish adults was studied with this purpose prospectively. Sex-specific apoA-I tertiles were examined regarding cardiometabolic risk. RESULTS AND
CONCLUSIONS: A total of 1044 men and 1067 women (aged 49+/-12 years at baseline) were followed up over 7.4 years. High serum apoA-I levels were significantly associated in multivariable analysis with female sex, aging, alcohol intake, (inversely) cigarette smoking and, in women, with systolic blood pressure. Risk of diabetes was predicted in logistic regression in both genders by top versus bottom apoA-I tertile (RR 1.98; [95%CI 1.31; 3.0]), additive to age, body mass index (BMI), C-reactive protein (CRP), HDL-cholesterol and lipid lowering drugs. By adding sex hormone-binding globulin to the model in a subset of the sample, the association between high apoA-I and incident diabetes was attenuated only in women. ApoA-I tertiles tended to be positively associated also with hypertension and CHD only in women but this did not reach significance. High compared with low serum apoA-I levels nearly double the risk for incident diabetes, additively to age, BMI, CRP, HDL-cholesterol among Turks. Systemic inflammation concomitant with prevailing MetS might turn apoA-I into proinflammatory particles. Copyright 2008 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19171400     DOI: 10.1016/j.ijcard.2008.12.066

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  14 in total

1.  An algorithm to predict risk of type 2 diabetes in Turkish adults: contribution of C-reactive protein.

Authors:  A Onat; G Can; H Yüksel; E Ayhan; Y Dogan; G Hergenç
Journal:  J Endocrinol Invest       Date:  2010-10-27       Impact factor: 4.256

2.  Dynamics shared by two related proinflammatory conditions, rheumatoid arthritis and metabolic syndrome.

Authors:  Altan Onat
Journal:  Eur J Rheumatol       Date:  2014-03-01

3.  Normal thyroid-stimulating hormone levels, autoimmune activation, and coronary heart disease risk.

Authors:  Altan Onat; Mesut Aydın; Günay Can; Etem Çelik; Servet Altay; Ahmet Karagöz; Evin Ademoğlu
Journal:  Endocrine       Date:  2014-05-03       Impact factor: 3.633

4.  High serum apolipoprotein E determines hypertriglyceridemic dyslipidemias, coronary disease and apoA-I dysfunctionality.

Authors:  Altan Onat; Günay Can; Ender Ornek; Erkan Ayhan; Nihan Erginel-Ünaltuna; Sani N Murat
Journal:  Lipids       Date:  2012-10-25       Impact factor: 1.880

5.  Glucose intolerance and risk of cardiovascular disease in Iranian men and women: results of the 7.6-year follow-up of the Tehran Lipid and Glucose Study (TLGS).

Authors:  F Hadaegh; D Khalili; N Fahimfar; M Tohidi; F Eskandari; F Azizi
Journal:  J Endocrinol Invest       Date:  2009-10       Impact factor: 4.256

6.  Elevated serum uric acid in nondiabetic people mark pro-inflammatory state and HDL dysfunction and independently predicts coronary disease.

Authors:  Altan Onat; Günay Can; Ender Örnek; Servet Altay; Murat Yüksel; Evin Ademoğlu
Journal:  Clin Rheumatol       Date:  2013-08-11       Impact factor: 2.980

7.  Impaired fasting glucose: Pro-diabetic, "atheroprotective" and modified by metabolic syndrome.

Authors:  Altan Onat; Mesut Aydın; Günay Can; H Altuğ Cakmak; Bayram Köroğlu; Ayşem Kaya; Evin Ademoğlu
Journal:  World J Diabetes       Date:  2013-10-15

8.  Atherogenic index of plasma as predictors for metabolic syndrome, hypertension and diabetes mellitus in Taiwan citizens: a 9-year longitudinal study.

Authors:  Yen-Wei Li; Tung-Wei Kao; Pi-Kai Chang; Wei-Liang Chen; Li-Wei Wu
Journal:  Sci Rep       Date:  2021-05-10       Impact factor: 4.379

9.  Dynamics in Cardiometabolic Risk among Turkish Adults: Similarities to that in Iranians?

Authors:  Altan Onat
Journal:  Int J Prev Med       Date:  2011-04

Review 10.  Metabolic syndrome: definitions and controversies.

Authors:  Eva Kassi; Panagiota Pervanidou; Gregory Kaltsas; George Chrousos
Journal:  BMC Med       Date:  2011-05-05       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.